These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7361649)

  • 1. Intravenous quinidine: pharmacokinetic properties and effects on left ventricular performance in humans.
    Ochs HR; Grube E; Greenblatt DJ; Woo E; Bodem G
    Am Heart J; 1980 Apr; 99(4):468-75. PubMed ID: 7361649
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of diphenylhydantoin (Dilantin) and quinidine on left ventricular function in dogs.
    Mierzwiak DS; Mitchell JH; Shapiro W
    Am Heart J; 1967 Dec; 74(6):780-91. PubMed ID: 6073358
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of oral quinidine on left ventricular performance in normal subjects and patients with congestive cardiomyopathy.
    Crawford MH; White DH; O'Rourke RA
    Am J Cardiol; 1979 Oct; 44(4):714-8. PubMed ID: 484501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Action of fomocaine on heart and circulation (author's transl)].
    Reuter N; Meyer F; Ziegenmeyer J; Bock M
    Arzneimittelforschung; 1975; 25(12):1900-6. PubMed ID: 1243660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of intravenously administered quinidine on the transplanted human heart.
    Mason JW; Winkle RA; Ingels NB; Daughters GT; Harrison DC; Stinson EB
    Am J Cardiol; 1977 Jul; 40(1):99-104. PubMed ID: 327786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac effects of treatment with quinidine and digoxin, alone and in combination.
    Schenck-Gustafsson K; Jogestrand T; Brodin LA; Nordlander R; Dahlqvist R
    Am J Cardiol; 1983 Mar; 51(5):777-82. PubMed ID: 6829437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of quinidine on ventricular repolarization.
    Brugada J; Sassine A; Escande D; Masse C; Puech P
    Eur Heart J; 1987 Dec; 8(12):1340-5. PubMed ID: 3436332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of glucagon in the treatment of quinidine toxicity in the heart.
    Prasad K
    Cardiovasc Res; 1977 Jan; 11(1):55-63. PubMed ID: 832287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of pharmacological, biophasic, and biological half-lives of quinidine in rabbits.
    Isaacs VE; Schoenwald RD
    J Pharm Sci; 1974 Jul; 63(7):1119-24. PubMed ID: 4851911
    [No Abstract]   [Full Text] [Related]  

  • 10. Normal myocardial contractile state in the presence of quinidine.
    Markiewicz W; Winkle R; Binetti G; Kernoff R; Harrison DC
    Circulation; 1976 Jan; 53(1):101-6. PubMed ID: 1244230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressant effects of quinidine gluconate on left ventricular function in conscious dogs with and without volume overload.
    Engler RL; Le Winter MM; Karliner JS
    Circulation; 1979 Oct; 60(4):828-35. PubMed ID: 476888
    [No Abstract]   [Full Text] [Related]  

  • 12. Myocardial contractility in patients with ischemic heart disease during long-term administration of quinidine and procainamide. Direct measurement of segmental shortening with radiopaque epicardial markers.
    Smitherman TC; Gottlich CM; Narahara KA; Osborn RC; Platt M; Rude RE; Lipscomb K
    Chest; 1979 Nov; 76(5):552-6. PubMed ID: 498828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiography, a non-invasive method for the investigation of heart morphology and function in laboratory dogs: 2. Effects of minoxidil and quinidine on the left ventricle function.
    Hanton G; Lodola A
    Lab Anim; 1998 Apr; 32(2):183-90. PubMed ID: 9587901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reactivity of atrial and ventricular pacemakers to quinidine.
    Nye CE; Roberts J
    J Pharmacol Exp Ther; 1966 Apr; 152(1):67-74. PubMed ID: 5937403
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of the ouabain-quinidine interaction on left ventricular and left atrial function in conscious dogs.
    Goldman S; Hager WD; Olajos M; Perrier D; Mayersohn M
    Circulation; 1983 May; 67(5):1054-8. PubMed ID: 6831670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.
    Greenblatt DJ; Pfeifer HJ; Ochs HR; Franke K; MacLaughlin DS; Smith TW; Koch-Weser J
    J Pharmacol Exp Ther; 1977 Aug; 202(2):365-78. PubMed ID: 577934
    [No Abstract]   [Full Text] [Related]  

  • 17. Improvement of exercise-induced left ventricular dysfunction with oral propranolol in patients with coronary heart disease.
    Battler A; Ross J; Slutsky R; Pfisterer M; Ashburn W; Froelicher V
    Am J Cardiol; 1979 Aug; 44(2):318-24. PubMed ID: 463770
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacology and clinical biopharmacy of quinidine].
    Huynh-Ngoc T; Sirois G
    J Pharm Belg; 1974 Mar; 29(2):152-80. PubMed ID: 4840388
    [No Abstract]   [Full Text] [Related]  

  • 19. The electrophysiological effects of intramuscular guinidine on the atrioventricular conducting system in man.
    Josephson ME; Seides SF; Batsford WP; Weisfogel GM; Akhtar M; Caracta AR; Lau SH; Damato AN
    Am Heart J; 1974 Jan; 87(1):55-64. PubMed ID: 4817489
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of digoxin-induced inotropism during quinidine administration.
    Steiness E; Waldorff S; Hansen PB; Kjaergård H; Buch J; Egeblad H
    Clin Pharmacol Ther; 1980 Jun; 27(6):791-5. PubMed ID: 7379447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.